0 1 [ [ ( 1 15 Glucocorticoid glucocorticoid NN 16 25 receptors receptor NNS 26 28 in in IN 29 39 peripheral peripheral JJ 40 45 blood blood NN 46 57 lymphocytes lymphocyte NNS 58 60 of of IN 61 69 patients patient NNS 70 74 with with IN 75 84 bronchial bronchial JJ 85 91 asthma asthma NN 91 92 ] ] ) 94 106 Quantitation Quantitation NNP 107 109 of of IN 110 124 glucocorticoid glucocorticoid NN 125 134 receptors receptor NNS 135 136 ( ( ( 136 139 GCR GCR NNP 139 140 ) ) ) 141 144 and and CC 145 148 the the DT 149 154 study study NN 155 157 of of IN 158 163 their their PRP$ 164 172 affinity affinity NN 173 176 for for IN 177 197 glucocorticosteroids glucocorticosteroid NNS 198 199 ( ( ( 199 202 GCS GCS NNP 202 203 ) ) ) 204 208 were be VBD 209 213 made make VBN 214 216 in in IN 217 227 peripheral peripheral JJ 228 233 blood blood NN 234 245 lymphocytes lymphocyte NNS 246 248 of of IN 249 258 bronchial bronchial JJ 259 265 asthma asthma NN 266 267 ( ( ( 267 269 BA BA NNP 269 270 ) ) ) 271 279 patients patient NNS 280 282 in in IN 283 296 consideration consideration NN 297 299 of of IN 300 303 GCR GCR NNP 304 313 treatment treatment NN 314 317 and and CC 318 323 serum serum NN 324 330 levels level NNS 331 333 of of IN 334 344 endogenous endogenous JJ 345 353 cortisol cortisol NN 353 354 . . . 355 357 It it PRP 358 360 is be VBZ 361 367 stated state VBN 368 372 that that IN 373 376 GCR GCR NNP 377 379 of of IN 380 387 healthy healthy JJ 388 396 controls control NNS 397 400 and and CC 401 414 GCS-untreated gcs-untreated JJ 415 423 patients patient NNS 424 435 outnumbered outnumber VBD 436 441 those those DT 442 444 of of IN 445 463 cortisol-dependent cortisol-dependent JJ 464 466 BA BA NNP 467 475 patients patient NNS 476 478 on on IN 479 486 hormone hormone NN 487 494 therapy therapy NN 494 495 . . . 496 505 Following follow VBG 506 521 discontinuation discontinuation NN 522 524 of of IN 525 539 glucocorticoid glucocorticoid NN 540 545 drugs drug NNS 546 549 GCR gcr NN 550 555 count count NN 556 558 in in IN 559 577 cortisol-dependent cortisol-dependent JJ 578 580 BA BA NNP 581 586 tends tend VBZ 587 589 to to TO 590 594 rise rise VB 594 595 . . . 596 606 Endogenous endogenous JJ 607 615 cortisol cortisol NN 616 619 has have VBZ 620 622 no no DT 623 629 effect effect NN 630 632 on on IN 633 636 GCR GCR NNP 637 642 level level NN 643 652 estimated estimate VBN 653 655 by by IN 656 672 3H-triamcinolone 3h-triamcinolone JJ 673 682 acetonide acetonide NN 682 683 . . .